Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Low frequency of calreticulin mutations in MDS patients

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 2013; 369: 2379–2390.

    Article  CAS  Google Scholar 

  2. Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 2013; 369: 2391–2405.

    Article  CAS  Google Scholar 

  3. Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M . Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 2009; 417: 651–666.

    Article  CAS  Google Scholar 

  4. Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM et al. Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J 2010; 24: 665–683.

    Article  CAS  Google Scholar 

  5. Wang WA, Groenendyk J, Michalak M . Calreticulin signaling in health and disease. Int J Biochem Cell Biol 2012; 44: 842–846.

    Article  CAS  Google Scholar 

  6. Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, Bleackley RC et al. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 1994; 367: 476–480.

    Article  CAS  Google Scholar 

  7. Rotunno G, Mannarelli C, Guglielmelli P, Pacilli A, Pancrazzi A, Pieri L et al. Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. Blood 2013; 123: 1552–1555.

    Article  Google Scholar 

  8. Rumi E, Pietra D, Ferretti V, Klampfl T, Harutyunyan AS, Milosevic JD et al. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood 2013; 123: 1544–1551.

    Article  Google Scholar 

  9. Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH et al. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia, 2014; e-pub ahead of print 9 January 2014; doi:10.1038/leu.2014.3.

    Article  CAS  Google Scholar 

  10. Thol F, Suchanek KJ, Koenecke C, Stadler M, Platzbecker U, Thiede C et al. SETBP1 mutation analysis in 944 patients with MDS and AML. Leukemia 2013; 27: 2072–2075.

    Article  CAS  Google Scholar 

  11. Thol F, Kolking B, Hollink IH, Damm F, van den Heuvel-Eibrink MM, Michel Zwaan C et al. Analysis of NUP98/NSD1 translocations in adult AML and MDS patients. Leukemia 2012; 27: 750–754.

    Article  Google Scholar 

  12. Panagiota V, Thol F, Markus B, Fehse B, Alchalby H, Badbaran A et al. Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation. Leukemia, 2014; e-pub ahead of print 7 February 2014; doi:10.1038/leu.2014.66.

    Article  CAS  Google Scholar 

  13. Tefferi A, Thiele J, Vannucchi AM, Barbui T . An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms. Leukemia, 2014; e-pub ahead of print 20 January 2014; doi:10.1038/leu.2014.35.

    Article  CAS  Google Scholar 

  14. Hou HA, Kuo YY, Chou WC, Chen PH, Tien HF . Calreticulin mutation was rarely detected in patients with myelodysplastic syndrome. Leukemia, 2014; e-pub ahead of print 17 February 2014; doi:10.1038/leu.2014.71.

    Article  CAS  Google Scholar 

  15. Broseus J, Lippert E, Klampfl T, Jeromin S, Zipperer E, Florensa L et al. Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosis. Leukemia 2014; 28: 1374–1376.

    Article  CAS  Google Scholar 

  16. Patnaik MM, Belachew A, Finke C, Lasho TL, Hanson CA, Tefferi A . CALR mutations are infrequent in WHO-defined refractory anemia with ring sideroblasts. Leukemia 2014; 28: 1370–1371.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are indebted to all patients and contributing doctors. We thank Elke Dammann and Wolfgang Kühnau for support in sample and data acquisition. This study was supported by grants 109003, 110284, 110287 and 110292 from Deutsche Krebshilfe; grants DJCLS H09/1f, R 10/22 and SP 12/02 from the Deutsche-José-Carreras Leukämie-Stiftung e.V; the German Federal Ministry of Education and Research grant 01EO0802 (IFB-Tx); DFG grant HE 5240/5-1; and grants from Hamburger Krebsgesellschaft, Erich und Gertrud Roggenbuck Stiftung and Dieter-Schlag Stiftung.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Heuser.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heuser, M., Panagiota, V., Koenecke, C. et al. Low frequency of calreticulin mutations in MDS patients. Leukemia 28, 1933–1934 (2014). https://doi.org/10.1038/leu.2014.165

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2014.165

This article is cited by

Search

Quick links